News

Dealmaking is in style again under President Donald Trump. Potential takeover targets include C3.ai, Viking Therapeutics, and ...
Gilead Sciences, Inc. has announced that it has received new approval from the U.S. Food and Drug Administration (FDA) for a ...
An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...
On Stocktwits, retail sentiment around Pheton is trending in the ‘extremely bullish’ territory, coupled with ‘extremely high’ ...
The president threatened to “deploy every tool” in the administration’s arsenal if drug companies don’t cut certain prices by ...
As we approach the 10th anniversary of the amendment to Federal Rule of Civil Procedure 26(b)(1), which called for “proportionality” of discovery requests and responses, it is appropriate to provide ...
Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.
Pharmaceutical stocks slumped after President Donald Trump sent letters to 17 drugmakers with an ultimatum to reduce drug ...
Earnings watch - Notable companies due to report include Palantir Technologies ( PLTR ), MercadoLibre ( MELI ), Wayfair ( W ) ...
Aside from the MFN order, President Trump is also in the process of negotiating tariffs with countries all over the world. It ...
Bristol-Myers Squibb Company beats revenue forecasts & raises 2025 guidance. Click for key BMY catalysts, risks, and outlook ...
Over the past few days, shares of Pheton have experienced an extraordinary and unexpected decline in its share price, which the Company believes may have been triggered by a speculative article ...